United States Biotechnology & Medical Research

CRISPR Therapeutics AG (CRSP)

Track

Over the past 90 days, CRISPR Therapeutics AG has seen exclusively insider selling activity, totaling approximately $210,577. The most recent transaction involved the Chief Medical Officer selling shares in late May. This follows a period of broader executive divestment, occurring against a backdrop of a 15.8% decline in stock price and a recent earnings report miss.
Ticker: CRSP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CRISPR Therapeutics AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Patel Naimish
Chief Medical Officer
1 sale — total 210,577 USD
Sale 29 May 2026
Value US$2,808,852.44 | Price 166.91 | Shares 27,723
Sale 23 Mar 2026
Value US$4,361,506.28 | Price 380.31 | Shares 82,616
Sale 23 Mar 2026
Value US$173,460.24 | Price 46.78 | Shares 3,708
Sale 23 Mar 2026
Value US$148,853.96 | Price 46.78 | Shares 3,182
Sale 16 Mar 2026
Value US$152,019.00 | Price 48.26 | Shares 3,150
Sale 16 Mar 2026
Value US$194,053.46 | Price 48.26 | Shares 4,021
Sale 16 Mar 2026
Value US$282,224.48 | Price 48.26 | Shares 5,848
Sale 16 Mar 2026
Value US$166,497.00 | Price 48.26 | Shares 3,450
Sale 16 Mar 2026
Value US$499,442.74 | Price 48.26 | Shares 10,349
Sale 11 Mar 2026
Value US$517,334.40 | Price 52.80 | Shares 9,798
Sale 11 Mar 2026
Value US$147,840.00 | Price 52.80 | Shares 2,800
Sale 19 Feb 2026
Value US$366,324.86 | Price 52.58 | Shares 6,967
Sale 19 Feb 2026
Value US$111,048.96 | Price 52.58 | Shares 2,112
Planned sale 22 Jan 2026
Value US$2,104,964.68 | Price 60.19 | Shares 34,972
Proposed sale 22 Jan 2026
Value US$3,648,600.00 | Price 60.81 | Shares 60,000
Proposed sale 22 Jan 2026
Value US$2,105,069.60 | Price 60.19 | Shares 34,972
Planned sale 22 Jan 2026
Value US$3,613,800.00 | Price 60.23 | Shares 60,000
Planned sale 20 Jan 2026
Value US$446,340.70 | Price 52.10 | Shares 8,567
Planned sale 20 Jan 2026
Value US$1,106,157.13 | Price 51.61 | Shares 21,433
Proposed sale 20 Jan 2026
Value US$1,578,300.00 | Price 52.61 | Shares 30,000
Planned sale 6 Jan 2026
Value US$347,009.82 | Price 60.21 | Shares 5,763
Planned sale 6 Jan 2026
Value US$300,240.00 | Price 60.00 | Shares 5,004
Planned sale 6 Jan 2026
Value US$1,139,386.05 | Price 60.18 | Shares 18,933
Proposed sale 6 Jan 2026
Value US$1,786,635.87 | Price 60.16 | Shares 29,700
Planned sale 22 Dec 2025
Value US$56,885.80 | Price 56.89 | Shares 1,000
Planned sale 22 Dec 2025
Value US$308,262.38 | Price 56.33 | Shares 5,472
Planned sale 22 Dec 2025
Value US$194,400.56 | Price 55.10 | Shares 3,528
Proposed sale 22 Dec 2025
Value US$559,548.00 | Price 55.95 | Shares 10,000
Sale 17 Oct 2025
Value US$3,456,279.45 | Price 67.91 | Shares 50,895
Sale 14 Oct 2025
Value US$71,661.60 | Price 66.60 | Shares 1,076
Sale 14 Oct 2025
Value US$282,517.20 | Price 66.60 | Shares 4,242
Sale 18 Aug 2025
Value US$760,660.15 | Price 58.15 | Shares 13,081
Buy 6 Aug 2025
Value US$1,140,600.00 | Price 57.03 | Shares 20,000
Buy 16 Jul 2025
Value US$49,999,945.49 | Price 52.03 | Shares 960,983
Buy 16 Jul 2025
Value US$1,161,257.57 | Price 52.03 | Shares 22,319
Buy 16 Jul 2025
Value US$338,715.30 | Price 52.03 | Shares 6,510
Sale 29 May 2025
Value US$141,316.08 | Price 35.94 | Shares 3,932
Buy 3 Apr 2025
Value US$49,703.68 | Price 32.96 | Shares 1,508
Sale 21 Mar 2025
Value US$131,317.55 | Price 41.23 | Shares 3,185
Sale 21 Mar 2025
Value US$90,582.31 | Price 41.23 | Shares 2,197
Sale 21 Mar 2025
Value US$70,668.22 | Price 41.23 | Shares 1,714
Sale 21 Mar 2025
Value US$413,578.13 | Price 41.23 | Shares 10,031
Sale 17 Mar 2025
Value US$157,251.60 | Price 41.80 | Shares 3,762
Sale 12 Mar 2025
Value US$193,293.84 | Price 43.32 | Shares 4,462
Sale 12 Mar 2025
Value US$8,230.80 | Price 43.32 | Shares 190
Sale 12 Mar 2025
Value US$48,345.12 | Price 43.32 | Shares 1,116
Sale 11 Mar 2025
Value US$423,054.66 | Price 42.42 | Shares 9,973
Sale 11 Mar 2025
Value US$50,819.16 | Price 42.42 | Shares 1,198
Sale 11 Mar 2025
Value US$120,897.00 | Price 42.42 | Shares 2,850
Buy 26 Feb 2025
Value US$313,947.90 | Price 44.85 | Shares 7,000
Planned sale 19 Feb 2025
Value US$1,013,563.80 | Price 55.21 | Shares 18,360
Sale 19 Feb 2025
Value US$365,798.40 | Price 52.80 | Shares 6,928
Sale 19 Feb 2025
Value US$17,582.40 | Price 52.80 | Shares 333
Sale 19 Feb 2025
Value US$102,801.60 | Price 52.80 | Shares 1,947
Sale 18 Feb 2025
Value US$516,690.75 | Price 53.85 | Shares 9,595
Planned sale 18 Feb 2025
Value US$640,782.00 | Price 55.05 | Shares 11,640
Proposed sale 18 Feb 2025
Value US$2,349,900.00 | Price 52.22 | Shares 45,000
Planned sale 2 Dec 2024
Value US$826,564.50 | Price 55.10 | Shares 15,000
Planned sale 11 Nov 2024
Value US$387,081.33 | Price 56.27 | Shares 6,879
Planned sale 11 Nov 2024
Value US$1,281,597.03 | Price 55.43 | Shares 23,121
Proposed sale 11 Nov 2024
Value US$4,114,500.00 | Price 54.86 | Shares 75,000
Sale 14 Oct 2024
Value US$50,398.92 | Price 46.28 | Shares 1,089
Sale 14 Oct 2024
Value US$198,680.04 | Price 46.28 | Shares 4,293
Sale 21 Jun 2024
Value US$188,798.94 | Price 56.09 | Shares 3,366
Planned sale 15 Apr 2024
Value US$72,721.96 | Price 60.40 | Shares 1,204
Planned sale 15 Apr 2024
Value US$1,100,509.56 | Price 59.88 | Shares 18,378
Proposed sale 15 Apr 2024
Value US$1,173,230.07 | Price 59.91 | Shares 19,582
Proposed sale 22 Mar 2024
Value US$3,699,269.45 | Price 72.87 | Shares 50,767
Sale 15 Mar 2024
Value US$256,159.56 | Price 72.69 | Shares 3,524
Planned sale 15 Mar 2024
Value US$685,817.97 | Price 73.06 | Shares 9,387
Planned sale 15 Mar 2024
Value US$763,810.18 | Price 71.97 | Shares 10,613
Proposed sale 15 Mar 2024
Value US$1,449,628.00 | Price 72.48 | Shares 20,000
Sale 12 Mar 2024
Value US$85,308.24 | Price 74.44 | Shares 1,146
Sale 12 Mar 2024
Value US$341,158.52 | Price 74.44 | Shares 4,583
Sale 11 Mar 2024
Value US$219,206.26 | Price 78.26 | Shares 2,801
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-01 2026-05-29 S Sale
1.9
Patel Naimish

Chief Medical Officer

Officer
27,723 +13.2%
166.91
US$2,808,852 		27,723 +13.2% 166.91 US$2,808,852
2026-03-24 2026-03-23 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
82,616 -12.6%
380.31
US$4,361,506 		82,616 -12.6% 380.31 US$4,361,506
2026-03-24 2026-03-23 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
53,953 -26.1%
290.24
US$3,932,237 		53,953 -26.1% 290.24 US$3,932,237
2026-03-24 2026-03-23 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
3,182 -3.3%
46.78
US$148,854 		3,182 -3.3% 46.78 US$148,854
2026-03-17 2026-03-16 S Sale
1.9
Patel Naimish

Chief Medical Officer

Officer
3,150 -19.3%
48.26
US$152,019 		3,150 -19.3% 48.26 US$152,019
2026-03-17 2026-03-16 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
4,021 -22.6%
48.26
US$194,053 		4,021 -22.6% 48.26 US$194,053
2026-03-17 2026-03-16 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
5,848 -24.7%
48.26
US$282,224 		5,848 -24.7% 48.26 US$282,224
2026-03-17 2026-03-16 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
3,450 -3.6%
48.26
US$166,497 		3,450 -3.6% 48.26 US$166,497
2026-03-17 2026-03-16 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
10,349 -4.0%
48.26
US$499,443 		10,349 -4.0% 48.26 US$499,443
2026-03-12 2026-03-11 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
9,798 -4.0%
52.80
US$517,334 		9,798 -4.0% 52.80 US$517,334
2026-03-12 2026-03-11 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
2,800 -3.1%
52.80
US$147,840 		2,800 -3.1% 52.80 US$147,840
2026-02-20 2026-02-19 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
6,967 -3.0%
52.58
US$366,325 		6,967 -3.0% 52.58 US$366,325
2026-02-20 2026-02-19 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
2,112 -2.4%
52.58
US$111,049 		2,112 -2.4% 52.58 US$111,049
2026-01-26 2026-01-22 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
34,972 -83.8%
60.19
US$2,104,965 		34,972 -83.8% 60.19 US$2,104,965
2026-01-22 2026-01-22 PrS Proposed sale
3.9
Samarth Kulkarni

Officer

Officer
60,000
60.81
US$3,648,600 		60,000 60.81 US$3,648,600
2026-01-22 2026-01-22 PrS Proposed sale
2.3
RAJU PRASAD

Officer

Officer
34,972
60.19
US$2,105,070 		34,972 60.19 US$2,105,070
2026-01-22 2026-01-22 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
60,000 -30.9%
60.23
US$3,613,800 		60,000 -30.9% 60.23 US$3,613,800
2026-01-22 2026-01-20 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
8,567 -4.2%
52.10
US$446,341 		8,567 -4.2% 52.10 US$446,341
2026-01-22 2026-01-20 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
21,433 -9.6%
51.61
US$1,106,157 		21,433 -9.6% 51.61 US$1,106,157
2026-01-20 2026-01-20 PrS Proposed sale
3.9
Samarth Kulkarni

Officer

Officer
30,000
52.61
US$1,578,300 		30,000 52.61 US$1,578,300
2026-01-08 2026-01-06 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
5,763 -46.0%
60.21
US$347,010 		5,763 -46.0% 60.21 US$347,010
2026-01-08 2026-01-06 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
5,004 -28.5%
60.00
US$300,240 		5,004 -28.5% 60.00 US$300,240
2026-01-08 2026-01-06 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
18,933 -51.9%
60.18
US$1,139,386 		18,933 -51.9% 60.18 US$1,139,386
2026-01-06 2026-01-06 PrS Proposed sale
2.3
RAJU PRASAD

Officer

Officer
29,700
60.16
US$1,786,636 		29,700 60.16 US$1,786,636
2025-12-23 2025-12-22 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
1,000 -12.9%
56.89
US$56,886 		1,000 -12.9% 56.89 US$56,886
2025-12-23 2025-12-22 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
5,472 -41.3%
56.33
US$308,262 		5,472 -41.3% 56.33 US$308,262
2025-12-23 2025-12-22 PlS Planned sale
2.3
Prasad Raju

Chief Financial Officer

Officer
3,528 -21.0%
55.10
US$194,401 		3,528 -21.0% 55.10 US$194,401
2025-12-22 2025-12-22 PrS Proposed sale
2.3
RAJU PRASAD

Officer

Officer
10,000
55.95
US$559,548 		10,000 55.95 US$559,548
2025-10-20 2025-10-17 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
50,895 -16.7%
67.91
US$3,456,279 		50,895 -16.7% 67.91 US$3,456,279
2025-10-15 2025-10-14 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
1,076 -1.3%
66.60
US$71,662 		1,076 -1.3% 66.60 US$71,662
2025-10-15 2025-10-14 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
4,242 -2.0%
66.60
US$282,517 		4,242 -2.0% 66.60 US$282,517
2025-08-19 2025-08-18 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
13,081 -5.9%
58.15
US$760,660 		13,081 -5.9% 58.15 US$760,660
2025-08-08 2025-08-06 B Purchase
2.4
Treco Douglas A
Non-Executive Director
20,000 +1000.0%
57.03
US$1,140,600 		20,000 +1000.0% 57.03 US$1,140,600
2025-07-17 2025-07-16 B Purchase
3.1
George Simeon
Non-Executive Director
960,983 +124.9%
52.03
US$49,999,945 		960,983 +124.9% 52.03 US$49,999,945
2025-07-17 2025-07-16 B Purchase
3.1
George Simeon
Non-Executive Director
22,319 +10.3%
52.03
US$1,161,258 		22,319 +10.3% 52.03 US$1,161,258
2025-07-17 2025-07-16 B Purchase
3.1
George Simeon
Non-Executive Director
6,510 +10.3%
52.03
US$338,715 		6,510 +10.3% 52.03 US$338,715
2025-05-30 2025-05-29 S Sale
1.9
Patel Naimish

Chief Medical Officer

Officer
3,932 -39.3%
35.94
US$141,316 		3,932 -39.3% 35.94 US$141,316
2026-01-27 2025-04-03 B Purchase
1.9
Patel Naimish

Chief Medical Officer

Officer
1,508 +inf%
32.96
US$49,704 		1,508 +inf% 32.96 US$49,704
2025-03-24 2025-03-21 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
3,185 -3.8%
41.23
US$131,318 		3,185 -3.8% 41.23 US$131,318
2025-03-24 2025-03-21 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
2,197 -11.6%
41.23
US$90,582 		2,197 -11.6% 41.23 US$90,582
2025-03-24 2025-03-21 S Sale
2.8
Bruno Julianne

Chief Operating Officer

Officer
1,714 -14.0%
41.23
US$70,668 		1,714 -14.0% 41.23 US$70,668
2025-03-24 2025-03-21 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
10,031 -4.9%
41.23
US$413,578 		10,031 -4.9% 41.23 US$413,578
2025-03-18 2025-03-17 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
3,762 -22.8%
41.80
US$157,252 		3,762 -22.8% 41.80 US$157,252
2025-03-12 2025-03-12 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
4,462 -2.3%
43.32
US$193,294 		4,462 -2.3% 43.32 US$193,294
2025-03-12 2025-03-12 S Sale
2.8
Bruno Julianne

Chief Operating Officer

Officer
190 -2.2%
43.32
US$8,231 		190 -2.2% 43.32 US$8,231
2025-03-12 2025-03-12 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
1,116 -1.4%
43.32
US$48,345 		1,116 -1.4% 43.32 US$48,345
2025-03-12 2025-03-11 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
9,973 -5.2%
42.42
US$423,055 		9,973 -5.2% 42.42 US$423,055
2025-03-12 2025-03-11 S Sale
2.8
Bruno Julianne

Chief Operating Officer

Officer
1,198 -12.7%
42.42
US$50,819 		1,198 -12.7% 42.42 US$50,819
2025-03-12 2025-03-11 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
2,850 -3.5%
42.42
US$120,897 		2,850 -3.5% 42.42 US$120,897
2025-02-28 2025-02-26 B Purchase
2.8
Greene John
Non-Executive Director
7,000 +inf%
44.85
US$313,948 		7,000 +inf% 44.85 US$313,948
2025-02-21 2025-02-19 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
18,360 -9.7%
55.21
US$1,013,564 		18,360 -9.7% 55.21 US$1,013,564
2025-02-19 2025-02-19 S Sale
2.8
Bruno Julianne

Chief Operating Officer

Officer
333 -4.5%
52.80
US$17,582 		333 -4.5% 52.80 US$17,582
2025-02-19 2025-02-19 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
1,947 -2.5%
52.80
US$102,802 		1,947 -2.5% 52.80 US$102,802
2025-02-19 2025-02-19 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
6,928 -3.5%
52.80
US$365,798 		6,928 -3.5% 52.80 US$365,798
2025-02-19 2025-02-18 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
9,595 -11.6%
53.85
US$516,691 		9,595 -11.6% 53.85 US$516,691
2025-02-19 2025-02-18 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
11,640 -5.6%
55.05
US$640,782 		11,640 -5.6% 55.05 US$640,782
2025-02-18 2025-02-18 PrS Proposed sale
3.9
Samarth Kulkarni

Officer

Officer
45,000
52.22
US$2,349,900 		45,000 52.22 US$2,349,900
2024-12-04 2024-12-02 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
15,000 -7.6%
55.10
US$826,564 		15,000 -7.6% 55.10 US$826,564
2024-11-13 2024-11-11 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
6,879 -3.4%
56.27
US$387,081 		6,879 -3.4% 56.27 US$387,081
2024-11-13 2024-11-11 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
23,121 -10.2%
55.43
US$1,281,597 		23,121 -10.2% 55.43 US$1,281,597
2024-11-12 2024-11-11 PrS Proposed sale
3.9
Dr. Samarth Kulkarni

Officer

Officer
75,000
54.86
US$4,114,500 		75,000 54.86 US$4,114,500
2024-10-15 2024-10-14 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
1,089 -1.7%
46.28
US$50,399 		1,089 -1.7% 46.28 US$50,399
2024-10-15 2024-10-14 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
4,293 -1.9%
46.28
US$198,680 		4,293 -1.9% 46.28 US$198,680
2024-06-24 2024-06-21 S Sale
2.8
Bruno Julianne

Chief Operating Officer

Officer
3,366 -33.3%
56.09
US$188,799 		3,366 -33.3% 56.09 US$188,799
2024-04-17 2024-04-15 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
1,204 -0.6%
60.40
US$72,722 		1,204 -0.6% 60.40 US$72,722
2024-04-17 2024-04-15 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
18,378 -8.1%
59.88
US$1,100,510 		18,378 -8.1% 59.88 US$1,100,510
2024-04-15 2024-04-15 PrS Proposed sale
3.9
SAMARTH KULKARNI

Officer; Director

Executive Director
19,582
59.91
US$1,173,230 		19,582 59.91 US$1,173,230
2024-03-22 2024-03-22 PrS Proposed sale
PHUONG KHANH MORROW

Officer

Officer
50,767
72.87
US$3,699,269 		50,767 72.87 US$3,699,269
2024-03-18 2024-03-15 S Sale
2.3
Prasad Raju

Chief Financial Officer

Officer
3,524 -35.2%
72.69
US$256,160 		3,524 -35.2% 72.69 US$256,160
2024-03-18 2024-03-15 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
9,387 -4.3%
73.06
US$685,818 		9,387 -4.3% 73.06 US$685,818
2024-03-18 2024-03-15 PlS Planned sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
10,613 -4.7%
71.97
US$763,810 		10,613 -4.7% 71.97 US$763,810
2024-03-15 2024-03-15 PrS Proposed sale
3.9
SAMARTH KULKARNI

Officer; Director

Executive Director
20,000
72.48
US$1,449,628 		20,000 72.48 US$1,449,628
2024-03-12 2024-03-12 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
1,146 -1.8%
74.44
US$85,308 		1,146 -1.8% 74.44 US$85,308
2024-03-12 2024-03-12 S Sale
3.9
Kulkarni Samarth

Chief Executive Officer

Executive Director
4,583 -2.2%
74.44
US$341,159 		4,583 -2.2% 74.44 US$341,159
2024-03-12 2024-03-11 S Sale
3.7
KASINGER JAMES R.

General Counsel and Secretary

Officer
2,801 -4.5%
78.26
US$219,206 		2,801 -4.5% 78.26 US$219,206
Explore more

More insider trading research around CRISPR Therapeutics AG

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America